Vancouver, BC -- (SBWIRE) -- 04/22/2021 -- The latest study, titled "Global Next-Generation Biomanufacturing Market", published by Emergen Research, entails a thorough review of the present and future market trends in this specific business vertical. The report gathers viable information on the most prominent industry players, distribution channel, regional spectrum, market share, and size, in terms of value and volume, respectively, and revenue estimations over the forecast timeframe.

Next-generation biomanufacturing process uses advanced technologies such as Artificial Intelligence, augmented reality, etc., and offers seamless outcomes that are better in terms of quality compared to outcomes generated using first-generation process. The adoption rate of next-generation biomanufacturing process is growing among various biopharmaceutical companies and research institutes owing to more energy-efficiency reduced water requirement, less volume of solid waste, and comparatively lower carbon emissions in the environment.

To get a sample copy of the Global Next-Generation Biomanufacturing Market report, visit @ https://www.emergenresearch.com/request-sample/504

Further Key Findings in the Report:

In July 2018, Amgen opened a new next-generation biomanufacturing plant located in West Greenwich, R.I. campus. The company invested approximately USD 200 Million in this new facility.
In April 2020, Akron Biotech acquired Cambryn in Sarasota, Florida, from Cambryn Biologics. The facility is a biomanufacturing plant equipped with state-of-the-art equipment.
Biopharmaceutical Companies accounted for a 39% revenue share in the global market. This can be attributed to rapid technological advancements and increasing investor and governments funding.
North America accounted for the largest market share of a 30.2% in 2020. Key factors such as growing focus of biological research and increased financial support from investors and international organizations.
Key players operating in the market are Merck KGaA, Thermo Fisher Scientific Inc., Eppendorf AG, Danaher Corporation, GEA Group Aktiengesellschaft, Sartorius AG, bbi-biotech GmbH, Solaris Biotechnology Srl, Esco Group of Companies, Pierre Guérin, and PBS Biotech, Inc.

Next-Generation Biomanufacturing Market Segmentation:

For the purpose of this report, Emergen Research has segmented the next-generation biomanufacturing market based on type, application, end-use, and region as follows:

Type Outlook (Revenue: USD Billion; 2020–-2028)
Continuous Upstream Biomanufacturing
Single-Use Upstream Biomanufacturing
Downstream Biomanufacturing

Application Outlook (Revenue: USD Billion; 2020–-2028)
Monoclonal Antibodies
Hormones
Vaccines
Recombinant Proteins
Others

End-Use Outlook (Revenue: USD Billion; 2020–-2028)
Biopharmaceutical Companies
Research Institutions
CMOs/CDMOs

Key Regions analyzed in the report include:

North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
AsiaPacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Request customization of the report @ https://www.emergenresearch.com/request-for-customization/504

Elucidating the competitive scenario of the Global Next-Generation Biomanufacturing Market:

The comprehensive global Next-Generation Biomanufacturing market analysis includes meaningful insights into the competitive spectrum of this business sphere. It goes on to enlist the detailed profiles of each market competitor.
The latest report includes the industry share, production facilities, development prospects,and geographies served by each market player.
The study also showcases the extensive product portfolios of the prominent market contenders and offers critical data and information about the application scope, as well as specifications of these products.
In addition, the study presents the fundamental market insights, pricing range of products offered by these companies, and the gross profits and losses experienced by these players throughout their market tenures.

Table of Content

Chapter 1. Methodology & Sources
    1.1. Market Definition
    1.2. Research Scope 
    1.3. Methodology
    1.4. Research Sources
          1.4.1. Primary
          1.4.2. Secondary
          1.4.3. Paid Sources
    1.5. Market Estimation Technique
Chapter 2. Executive Summary
    2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Next-Generation Biomanufacturing Market Segmentation & Impact Analysis
    4.1. Next-Generation Biomanufacturing Market Segmentation Analysis
    4.2. Industrial Outlook
          4.2.1. Market indicators analysis
          4.2.2. Market drivers analysis
                    4.2.2.1. Continuous funding from governments and private investors
                    4.2.2.2. Increase in the number of biopharmaceutical industries
          4.2.3. Market restraints analysis
                    4.2.3.1. Low availability of required technology
                    4.2.3.2. Lack of awareness
    4.3. Technological Insights
    4.4. Regulatory Framework
    4.5. Porter's Five Forces Analysis
    4.6. Competitive Metric Space Analysis
    4.7. Price trend Analysis
    4.8. Covid-19 Impact Analysis

Chapter 5. Next-Generation Biomanufacturing Market By Type Insights & Trends, Revenue (USD Billion)
    5.1. Type Dynamics & Market Share, 2019 & 2027
          5.1.1. Continuous Upstream Biomanufacturing
          5.1.2. Single-Use Upstream Biomanufacturing
          5.1.3. Downstream Biomanufacturing

CONTINUED..!!

For more details on the Global Next-Generation Biomanufacturing Market report, visit @ https://www.emergenresearch.com/industry-report/next-generation-biomanufacturing-market

Thank you for reading our report. Please connect with us to know more about the report and its customization feature. Our team will ensure your queries are solved, and the report is customized to meet your requirements.

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs

Read Full Press Release: https://www.emergenresearch.com/press-release/global-next-generation-biomanufacturing-market